ASSESSING GEROTHERAPEUTIC POTENTIAL OF GLP-1 RECEPTOR AGONISTS

Abstract

Gerotherapeutics are drugs that target biological mechanisms of aging to achieve broad impacts on multiple chronic diseases of aging as well as geriatric syndromes. No drugs have yet been shown in clinical trials to act as gerotherapeutics.